BTG International Germany Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

BTG International Germany General Information

Description

Developer of biological drug delivery systems for cancer treatment. The company develops medical devices, cosmetic and pharmaceutical products including radiation delivering pods and drug delivery capsules for the treatment of cancer, enabling healthcare providers to provide better treatment to cancer patients.

Contact Information

Website
cellmed.de
Formerly Known As
CellMed
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Industriestrasse 19
  • 63755 Alzenau
  • Germany
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Boston Scientific
Vertical(s)
Corporate Office
  • Industriestrasse 19
  • 63755 Alzenau
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BTG International Germany Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 23-Sep-2020 Completed Generating Revenue
3. Merger/Acquisition 04-Mar-2005 Completed Product Development
2. Grant 01-Jan-2001 $1.72M $2.72M Completed Product Development
1. Early Stage VC 01-Jan-2001 $2.72M $2.72M Completed Product Development
To view BTG International Germany’s complete valuation and funding history, request access »

BTG International Germany Patents

BTG International Germany Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2709868-A1 Monolithic alginate implants crosslinked in situ Inactive 16-Jan-2008
EP-2082755-A1 Monolithic alginate implants networked in situ Inactive 16-Jan-2008
EP-2229190-A1 Monolithic in-situ cross-linked alginate implants Inactive 16-Jan-2008
US-20110097367-A1 Monolithic in-situ cross-linked alginate implants Inactive 16-Jan-2008
WO-2009090020-A1 Monolithic in-situ cross-linked alginate implants Inactive 16-Jan-2008 A61K8/733
To view BTG International Germany’s complete patent history, request access »

BTG International Germany Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BTG International Germany Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biocompatibles International Corporation Majority
IDP Industrial Development Partners Growth/Expansion Minority
To view BTG International Germany’s complete investors history, request access »

BTG International Germany FAQs

  • When was BTG International Germany founded?

    BTG International Germany was founded in 2000.

  • Where is BTG International Germany headquartered?

    BTG International Germany is headquartered in Alzenau, Germany.

  • What is the size of BTG International Germany?

    BTG International Germany has 20 total employees.

  • What industry is BTG International Germany in?

    BTG International Germany’s primary industry is Drug Delivery.

  • Is BTG International Germany a private or public company?

    BTG International Germany is a Private company.

  • What is BTG International Germany’s current revenue?

    The current revenue for BTG International Germany is .

  • How much funding has BTG International Germany raised over time?

    BTG International Germany has raised $2.72M.

  • Who are BTG International Germany’s investors?

    Biocompatibles International and IDP Industrial Development Partners have invested in BTG International Germany.

  • When was BTG International Germany acquired?

    BTG International Germany was acquired on 23-Sep-2020.

  • Who acquired BTG International Germany?

    BTG International Germany was acquired by Boston Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process